Manufacturer profileFUJIREBIO DIAGNOSTICS INC.
IndonesiaUnited States20 products registered
VerifiedKemenkes (Ministry of Health) · official registry
20
Total Products
19
Product Names
1
Product Classes
2
Risk Classes
Regulatory footprint
Search FUJIREBIO DIAGNOSTICS INC. across other regulatory registries
Thailand
European Union
Colombia
South Korea
Canada
EcuadorRisk classification breakdown
Distribution of products across risk classes
Kelas Resiko : B630.0% of total
Kelas Resiko : C1470.0% of total
Product class portfolio
Products organized by product class
Kelas : 2
ARCHITECT CA 19-9XR Reagent Kit, ALINITY i CA 125 II Controls, ARCHITECT Tacrolimus Whole Blood Precipitation Reagent, ARCHITECT Methotrexate Calibrators, ARCHITECT Methotrexate Extended Range Controls ... and 15 more products in this class
20 Products
Recent registrations (20 most recent)
Most recently registered products with Ministry of Health
ARCHITECT CA 19-9XR Reagent Kit
Oct 1, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ALINITY i CA 125 II Controls
Jul 31, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT Tacrolimus Whole Blood Precipitation Reagent
Jul 9, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT Methotrexate Calibrators
Jul 11, 2023
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
ARCHITECT Methotrexate Extended Range Controls
Jul 6, 2023
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
ARCHITECT Methotrexate Controls
Jun 27, 2023
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
ARCHITECT HE4 Controls
Jun 17, 2023
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT HE4 Reagent Kit
Jun 16, 2023
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT Cyclosporine Whole Blood Precipitation Reagent Kit
May 4, 2023
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ALINITY i Methotrexate Controls
Dec 9, 2022
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
ALINITY i Methotrexate Reagent Kit
Dec 9, 2022
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ALINITY i Methotrexate Extended Range Controls
Dec 9, 2022
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
ALINITY i Methotrexate Calibrators
Dec 9, 2022
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
ALINITY i CYFRA 21-1 Reagent Kit
Nov 28, 2022
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT Cyfra 21-1 Controls
Sep 12, 2022
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT Cyfra 21-1 Reagent Kit
Sep 8, 2022
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT Cyfra 21-1 Calibrators
Sep 8, 2022
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT HE4 Calibrators
Aug 29, 2022
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT Tacrolimus Reagent Kit
Aug 23, 2022
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT Tacrolimus Whole Blood Precipitation Reagent
May 5, 2021
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
About this profile
FUJIREBIO DIAGNOSTICS INC. from United States is a medical device manufacturer with 20 registered products in the Indonesia Ministry of Health database through Pure Global AI's free platform. The company produces 19 unique product types across 1 product class.
This page provides comprehensive manufacturer intelligence including complete product portfolio, risk class distribution, and product class analysis. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify manufacturers, analyze portfolios, and discover partnership opportunities efficiently.